# Drilling Tools International Corp: financial statements, quarterly

DTI · Nasdaq · CIK 1884516 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dti.md) · [Financials](/companies/dti/financials.md) · [Filings](/companies/dti/filings.md) · [Insiders](/companies/dti/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dti/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [38.1](/filings/0000950170-24-127007.md) | [35.2 d](/filings/0000950170-25-039259.md) | [37.0](/filings/0000950170-25-071056.md) | [37.5](/filings/0001193125-25-180544.md) | [40.1](/filings/0001193125-25-271536.md) | [39.8 d](/filings/0001193125-26-095973.md) | [42.9](/filings/0001193125-26-214074.md) | [39.4](/filings/0001193125-26-339814.md) | [38.8](/filings/0001193125-25-271536.md) | [38.5 d](/filings/0001193125-26-095973.md) | [38.0](/filings/0001193125-26-214074.md) | [38.1](/filings/0001193125-26-339814.md) |
| Selling, general and administrative | $m | [16.6](/filings/0000950170-24-127007.md) | [17.3 d](/filings/0000950170-25-039259.md) | [17.9](/filings/0000950170-25-071056.md) | [19.6](/filings/0001193125-25-180544.md) | [19.9](/filings/0001193125-25-271536.md) | [21.3 d](/filings/0001193125-26-095973.md) | [21.6](/filings/0001193125-26-214074.md) | [21.0](/filings/0001193125-26-339814.md) | [20.4](/filings/0001193125-25-271536.md) | [19.2 d](/filings/0001193125-26-095973.md) | [20.2](/filings/0001193125-26-214074.md) | [19.9](/filings/0001193125-26-339814.md) |
| Operating income | $m | [7.1](/filings/0000950170-24-127007.md) | [4.5 d](/filings/0000950170-25-039259.md) | [5.1](/filings/0000950170-25-071056.md) | [2.2](/filings/0000950170-24-094837.md) | [4.3](/filings/0000950170-24-127007.md) | [1.8 d](/filings/0000950170-25-039259.md) | [3.3](/filings/0000950170-25-071056.md) | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [2.1](/filings/0000950170-24-127007.md) | [(0.2) d](/filings/0000950170-25-039259.md) | [0.9](/filings/0000950170-25-071056.md) | [(0.1)](/filings/0001193125-25-180544.md) | [(0.4)](/filings/0001193125-25-271536.md) | [(0.4) d](/filings/0001193125-26-095973.md) | [(0.2)](/filings/0001193125-26-214074.md) | [0.7](/filings/0001193125-26-339814.md) | [0.4](/filings/0001193125-25-271536.md) | [(0.1) d](/filings/0001193125-26-095973.md) | [(0.6)](/filings/0001193125-26-214074.md) | [(0.1)](/filings/0001193125-26-339814.md) |
| Net income | $m | [4.3](/filings/0000950170-24-127007.md) | [3.8 d](/filings/0000950170-25-039259.md) | [3.1](/filings/0001193125-25-271536.md) | [0.4](/filings/0001193125-25-271536.md) | [0.9](/filings/0001193125-25-271536.md) | [(1.3) d](/filings/0001193125-26-095973.md) | [(1.7)](/filings/0001193125-26-214074.md) | [(2.4)](/filings/0001193125-26-339814.md) | [(0.9)](/filings/0001193125-25-271536.md) | [1.2 d](/filings/0001193125-26-095973.md) | [(1.5)](/filings/0001193125-26-214074.md) | [(1.8)](/filings/0001193125-26-339814.md) |
| Diluted EPS | $ per share | [0.14](/filings/0000950170-24-127007.md) | not reported | [0.11](/filings/0000950170-25-071056.md) | [0.01](/filings/0001193125-25-180544.md) | [0.03](/filings/0001193125-25-271536.md) | not reported | [(0.05)](/filings/0001193125-26-214074.md) | [(0.07)](/filings/0001193125-26-339814.md) | [(0.03)](/filings/0001193125-25-271536.md) | not reported | [(0.04)](/filings/0001193125-26-214074.md) | [(0.05)](/filings/0001193125-26-339814.md) |
| Basic EPS | $ per share | [0.14](/filings/0000950170-24-127007.md) | not reported | [0.11](/filings/0000950170-25-071056.md) | [0.01](/filings/0001193125-25-180544.md) | [0.03](/filings/0001193125-25-271536.md) | not reported | [(0.05)](/filings/0001193125-26-214074.md) | [(0.07)](/filings/0001193125-26-339814.md) | [(0.03)](/filings/0001193125-25-271536.md) | not reported | [(0.04)](/filings/0001193125-26-214074.md) | [(0.05)](/filings/0001193125-26-339814.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [4.0](/filings/0000950170-23-063319.md) | [6.0](/filings/0000950170-25-039259.md) | [14.1](/filings/0000950170-24-060334.md) | [6.8](/filings/0000950170-24-094837.md) | [12.0](/filings/0000950170-24-127007.md) | [6.2](/filings/0001193125-26-095973.md) | [2.8](/filings/0000950170-25-071056.md) | [1.1](/filings/0001193125-25-180544.md) | [4.4](/filings/0001193125-25-271536.md) | [3.6](/filings/0001193125-26-339814.md) | [2.8](/filings/0001193125-26-214074.md) | [2.5](/filings/0001193125-26-339814.md) |
| Current assets | $m | [45.6](/filings/0000950170-23-063319.md) | [46.4](/filings/0000950170-25-039259.md) | [65.6](/filings/0000950170-24-060334.md) | [60.8](/filings/0000950170-24-094837.md) | [68.7](/filings/0000950170-24-127007.md) | [68.1](/filings/0001193125-26-095973.md) | [67.4](/filings/0000950170-25-071056.md) | [66.1](/filings/0001193125-25-180544.md) | [64.7](/filings/0001193125-25-271536.md) | [64.9](/filings/0001193125-26-339814.md) | [68.7](/filings/0001193125-26-214074.md) | [73.8](/filings/0001193125-26-339814.md) |
| Total assets | $m | [131](/filings/0000950170-23-063319.md) | [132](/filings/0000950170-25-039259.md) | [167](/filings/0000950170-25-071056.md) | [167](/filings/0001193125-25-180544.md) | [219](/filings/0001193125-25-271536.md) | [222](/filings/0001193125-26-095973.md) | [233](/filings/0001193125-26-214074.md) | [230](/filings/0001193125-26-339814.md) | [227](/filings/0001193125-25-271536.md) | [222](/filings/0001193125-26-339814.md) | [225](/filings/0001193125-26-214074.md) | [229](/filings/0001193125-26-339814.md) |
| Current liabilities | $m | [23.9](/filings/0000950170-23-063319.md) | [22.3](/filings/0000950170-25-039259.md) | [34.1](/filings/0000950170-24-060334.md) | [30.9](/filings/0000950170-24-094837.md) | [52.0](/filings/0000950170-24-127007.md) | [31.0](/filings/0001193125-26-095973.md) | [34.8](/filings/0000950170-25-071056.md) | [32.0](/filings/0001193125-25-180544.md) | [31.8](/filings/0001193125-25-271536.md) | [30.8](/filings/0001193125-26-339814.md) | [31.9](/filings/0001193125-26-214074.md) | [33.9](/filings/0001193125-26-339814.md) |
| Total liabilities | $m | [46.6](/filings/0000950170-23-063319.md) | [43.8](/filings/0000950170-25-039259.md) | [75.4](/filings/0000950170-24-060334.md) | [74.1](/filings/0000950170-24-094837.md) | [95.7](/filings/0000950170-24-127007.md) | [102](/filings/0001193125-26-095973.md) | [110](/filings/0000950170-25-071056.md) | [108](/filings/0001193125-25-180544.md) | [106](/filings/0001193125-25-271536.md) | [99.3](/filings/0001193125-26-339814.md) | [104](/filings/0001193125-26-214074.md) | [109](/filings/0001193125-26-339814.md) |
| Long-term debt | $m | not reported | [0.0](/filings/0000950170-25-039259.md) | [20.0](/filings/0000950170-24-060334.md) | [19.2](/filings/0000950170-24-094837.md) | [17.9](/filings/0000950170-24-127007.md) | [19.7](/filings/0001193125-26-095973.md) | [19.0](/filings/0000950170-25-071056.md) | [17.5](/filings/0001193125-25-180544.md) | [16.3](/filings/0001193125-25-271536.md) | [14.8](/filings/0001193125-26-339814.md) | [13.3](/filings/0001193125-26-214074.md) | [9.0](/filings/0001193125-26-339814.md) |
| Current portion of debt | $m | not reported | [0.0](/filings/0000950170-25-039259.md) | [5.0](/filings/0000950170-24-060334.md) | [5.0](/filings/0000950170-24-094837.md) | [5.0](/filings/0000950170-24-127007.md) | [7.0](/filings/0001193125-26-095973.md) | [5.9](/filings/0000950170-25-071056.md) | [6.3](/filings/0001193125-25-180544.md) | [6.0](/filings/0001193125-25-271536.md) | [6.0](/filings/0001193125-26-339814.md) | [6.0](/filings/0001193125-26-214074.md) | [5.9](/filings/0001193125-26-339814.md) |
| Shareholders' equity | $m | [84.9](/filings/0000950170-24-127007.md) | [88.7](/filings/0001193125-25-271536.md) | [91.5](/filings/0001193125-25-271536.md) | [92.8](/filings/0001193125-25-271536.md) | [(123)](/filings/0001193125-25-271536.md) | [120](/filings/0001193125-26-095973.md) | [123](/filings/0001193125-25-180544.md) | [123](/filings/0001193125-25-180544.md) | [121](/filings/0001193125-25-271536.md) | [123](/filings/0001193125-26-339814.md) | [120](/filings/0001193125-26-214074.md) | [120](/filings/0001193125-26-339814.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [3.4 d](/filings/0000950170-24-127007.md) | [5.9 d](/filings/0000950170-25-039259.md) | [3.3](/filings/0000950170-25-071056.md) | [1.1 d](/filings/0001193125-25-180544.md) | [5.3 d](/filings/0001193125-25-271536.md) | [(3.7) d](/filings/0001193125-26-095973.md) | [2.4](/filings/0001193125-26-214074.md) | [2.2 d](/filings/0001193125-26-339814.md) | [10.0 d](/filings/0001193125-25-271536.md) | [5.3 d](/filings/0001193125-26-095973.md) | [(3.2)](/filings/0001193125-26-214074.md) | [(2.3) d](/filings/0001193125-26-339814.md) |
| Capital expenditure | $m | [12.2 d](/filings/0000950170-24-127007.md) | [7.0 d](/filings/0000950170-25-039259.md) | [6.2](/filings/0000950170-25-071056.md) | [10.1 d](/filings/0001193125-25-180544.md) | [3.4 d](/filings/0001193125-25-271536.md) | [3.2 d](/filings/0001193125-26-095973.md) | [5.0](/filings/0001193125-26-214074.md) | [7.6 d](/filings/0001193125-26-339814.md) | [3.5 d](/filings/0001193125-25-271536.md) | [4.0 d](/filings/0001193125-26-095973.md) | [7.7](/filings/0001193125-26-214074.md) | [4.2 d](/filings/0001193125-26-339814.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001193125-25-271536.md) | [0.0 d](/filings/0001193125-26-095973.md) | [0.0](/filings/0001193125-26-214074.md) | [0.6 d](/filings/0001193125-26-339814.md) | [0.5 d](/filings/0001193125-25-271536.md) | [0.1 d](/filings/0001193125-26-095973.md) | [0.7](/filings/0001193125-26-214074.md) | [0.0 d](/filings/0001193125-26-339814.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [19.7](/filings/0000950170-23-063319.md) | [19.7](/filings/0000950170-24-060334.md) | [20.7](/filings/0000950170-24-094837.md) | [30.0](/filings/0000950170-24-127007.md) | [29.8](/filings/0000950170-25-071056.md) | [30.9](/filings/0001193125-25-180544.md) | [33.5](/filings/0001193125-25-271536.md) | [35.6](/filings/0001193125-26-214074.md) | [35.6](/filings/0001193125-26-339814.md) | [35.4](/filings/0001193125-25-271536.md) | [35.1](/filings/0001193125-26-214074.md) | [35.3](/filings/0001193125-26-339814.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 35,282,224 at 2026-08-04, from the cover of the [10-Q filed 2026-08-07](/filings/0001193125-26-339814.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.